Evidence map›Paper›PMID 34224248›Full record

ReviewThe neuroradiology journal2022

A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19).

Bahar Bahranifard, Somayeh Mehdizadeh, Ali Hamidi, Alireza Khosravi, Ramin Emami, Kamran Mirzaei, Reza Nemati, Fatemeh Nemati, Majid Assadi, Ali Gholamrezanezhad

Open access · bronzeAbstract readReview
In one paragraph

Review in The neuroradiology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Bahar BahranifardDepartment of Neurology, Bushehr University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0003-2652-5481
Somayeh MehdizadehDepartment of Pathology, Bushehr University of Medical Sciences, Iran.
Ali HamidiDepartment of Medical Library and Information Science, Bushehr University of Medical Sciences, Iran.
Alireza KhosraviDepartment of Neurology, Zahedan University of Medical Sciences, Iran.
Ramin EmamiDepartment of Neurology, Abhar Medical Clinic, Iran.
Kamran MirzaeiDepartment of Community Medicine, Bushehr University of Medical Sciences, Iran.
Reza NematiDepartment of Neurology, Bushehr University of Medical Sciences, Iran.ORCID https://orcid.org/0000-0001-8155-8855
Fatemeh NematiDepartment of English Language and Literature, Persian Gulf University, Iran.
Majid AssadiDepartment of Molecular Imaging and Radionuclide Therapy (MIRT), The Persian Gulf Nuclear Medicine Research Center, Iran.ORCID https://orcid.org/0000-0002-2166-3765
Ali GholamrezanezhadKeck School of Medicine, University of Southern California (USC), USA.
Bushehr University of Medical Sciences · IRPersian Gulf University · IRUniversity of Southern California · USZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to various neurological manifestations. There is an urgent need for a summary of neuroimaging findings to accelerate diagnosis and treatment plans. We reviewed prospective and retrospective studies to classify neurological abnormalities observed in patients with the SARS-CoV-2 infection.

methodsThe relevant studies published in Scopus, PubMed and Clarivate Analytics databases were analysed. The search was performed for full-text articles published from 23 January 2020 to 23 February 2021.

resultsIn 23 studies the number of patients with SARS-CoV-2 infection was 20,850 and the number of patients with neurological manifestations was 1996 (9.5%). The total number of patients with neuroradiological abnormalities was 602 (2.8%). SARS-CoV-2 has led to various neuroimaging abnormalities which can be categorised by neuroanatomical localisation of lesions and their main probable underlying pathogenesis. Cranial nerve and spinal root abnormalities were cranial neuritis and polyradiculitis. Parenchymal abnormalities fell into four groups of: (a) thrombosis disorders, namely ischaemic stroke and sinus venous thrombosis; (b) endothelial dysfunction and damage disorders manifested as various types of intracranial haemorrhage and posterior reversible encephalopathy syndrome; (c) hypoxia/hypoperfusion disorders of leukoencephalopathy and watershed infarction; and (d) inflammatory disorders encompassing demyelinating disorders, encephalitis, vasculitis-like disorders, vasculopathy and cytotoxic lesions of the corpus callosum. Leptomeninges disorders included meningitis. Ischaemic stroke was the most frequent abnormality in these studies.

conclusionThe review study suggests that an anatomical approach to the classification of heterogeneous neuroimaging findings in patients with SARS-CoV-2 and neurological manifestations would lend itself well for use by practitioners in diagnosis and treatment planning.

Indexed as

Brain IschemiaCOVID-19Posterior Leukoencephalopathy SyndromeStrokeHumansProspective StudiesRetrospective StudiesSARS-CoV-2braincomputed tomographyCOVID-19magnetic resonanceNeuroradiologicalspinal

Identifiers

PMID34224248
PMCPMC8819585
OpenAlexW3178742156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.